Journey Medical (DERM) News Today $5.23 -0.12 (-2.24%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2024 EPS Forecast for Journey Medical Lowered by AnalystJourney Medical Co. (NASDAQ:DERM - Free Report) - Research analysts at Roth Capital lowered their FY2024 earnings per share estimates for Journey Medical in a note issued to investors on Monday, November 18th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per shNovember 21 at 6:51 AM | marketbeat.comJourney Medical management to meet virtually with B. RileyNovember 21 at 4:13 AM | markets.businessinsider.comFY2024 EPS Estimates for Journey Medical Raised by B. RileyJourney Medical Co. (NASDAQ:DERM - Free Report) - Stock analysts at B. Riley upped their FY2024 earnings per share (EPS) estimates for shares of Journey Medical in a research report issued to clients and investors on Monday, November 18th. B. Riley analyst K. Patel now forecasts that the companyNovember 20 at 6:39 AM | marketbeat.comDespite Journey Medical's Pullback, Insiders Still Gained US$118kNovember 16, 2024 | finance.yahoo.comJourney Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in OctoberJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 60,800 shares, a drop of 20.7% from the October 15th total of 76,700 shares. Based on an average trading volume of 88,700 shares, the short-interest ratio is currently 0.7 days. Approximately 0.6% of the company's shares are sold short.November 15, 2024 | marketbeat.comJourney Medical Reports Q3 2024 Earnings, Eyes Emrosi LaunchNovember 15, 2024 | markets.businessinsider.comLake Street Remains a Buy on Journey Medical Corp (DERM)November 13, 2024 | markets.businessinsider.comJourney Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 12, 2024 | globenewswire.comJourney Medical FY2024 EPS Forecast Boosted by Roth CapitalJourney Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital boosted their FY2024 earnings per share (EPS) estimates for Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per shNovember 7, 2024 | marketbeat.comJourney Medical price target raised to $11 from $8.50 at Alliance Global PartnersNovember 6, 2024 | markets.businessinsider.comQ3 EPS Estimates for Journey Medical Decreased by AnalystJourney Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital dropped their Q3 2025 EPS estimates for shares of Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of $0.20 per shareNovember 6, 2024 | marketbeat.comFDA Approves New Option for RosaceaNovember 5, 2024 | msn.comUS FDA approves Journey Medical's drug for long-term skin conditionNovember 5, 2024 | msn.comWhat's Going On With Journey Medical Stock Today?November 5, 2024 | msn.comJourney Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNovember 4, 2024 | globenewswire.comBiotech Stocks Facing FDA Decision In November 2024October 30, 2024 | markets.businessinsider.comJourney Medical Co. (NASDAQ:DERM) Short Interest UpdateJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 76,700 shares, a drop of 12.5% from the September 30th total of 87,700 shares. Approximately 0.8% of the company's stock are sold short. Based on an average daily volume of 62,700 shares, the days-to-cover ratio is presently 1.2 days.October 29, 2024 | marketbeat.comJourney Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceOctober 25, 2024 | globenewswire.comJourney Medical Co. (NASDAQ:DERM) Short Interest Up 10.5% in SeptemberJourney Medical Co. (NASDAQ:DERM - Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 87,700 shares, an increase of 10.5% from the September 15th total of 79,400 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average trading volume of 55,400 shares, the days-to-cover ratio is currently 1.6 days.October 15, 2024 | marketbeat.comShould you use biotin for thinning hair? Here’s what dermatologists sayOctober 12, 2024 | msn.comCase Study: Rare Subtype of Cutaneous Problem in a Breast Cancer PatientOctober 12, 2024 | msn.comJourney Medical (NASDAQ:DERM) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comJourney Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceOctober 3, 2024 | globenewswire.comMy Journey With HS, From Adolescence To AdulthoodOctober 1, 2024 | yahoo.comPVG Asset Management Corp Purchases New Holdings in Journey Medical Co. (NASDAQ:DERM)PVG Asset Management Corp acquired a new position in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 158,540 shares of the companOctober 1, 2024 | marketbeat.comMIGHTY 25: From PA to patient to advocate, Samantha Gomolka is a warriorSeptember 30, 2024 | yahoo.comObese Pit Bull Who Would ‘Eat While Lying Down’ Unbelievably Transformed After Weight Loss JourneySeptember 30, 2024 | msn.comWicklow volunteers to make 3,500-kilometre journey to donate vehicles to UkraineSeptember 30, 2024 | msn.comCan Journey Medical Corporation (NASDAQ:DERM) Improve Its Returns?September 28, 2024 | finance.yahoo.comReal Women on How They Worked Through Psoriasis & Psoriatic Arthritis in Their CareersSeptember 27, 2024 | msn.comWomen With This Scalp Condition May Be More Prone To Hair Loss. Here's How To Find ReliefSeptember 27, 2024 | yahoo.com10 Million People Suffer From This Scalp Condition. Here's How One Woman Found Relief.September 27, 2024 | msn.comJourney Medical Corp (DERM) Gets a Buy from Lake StreetSeptember 27, 2024 | markets.businessinsider.comNextech Launches Expanded Payments FunctionalitySeptember 25, 2024 | markets.businessinsider.comI Tried the Noninvasive Hair Loss Treatment Alma TED, and It Really WorkedSeptember 23, 2024 | msn.comSummit Health To Open In Former Crate & Barrel Store In BridgewaterSeptember 21, 2024 | msn.comSummit Health opens multispecialty facility in Fair Lawn, New JerseySeptember 20, 2024 | msn.comJourney Medical Co. (NASDAQ:DERM) Shares Sold by Acadian Asset Management LLCAcadian Asset Management LLC reduced its stake in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) by 57.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 94,404 shares of the companySeptember 19, 2024 | marketbeat.comJourney Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceSeptember 9, 2024 | globenewswire.comJourney Medical (NASDAQ:DERM) Earns Buy Rating from Analysts at Lake Street CapitalLake Street Capital began coverage on shares of Journey Medical in a research report on Friday. They set a "buy" rating and a $9.00 price objective for the company.September 6, 2024 | marketbeat.comJourney Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comCambridge Investment Research Advisors Inc. Takes $1.66 Million Position in Journey Medical Co. (NASDAQ:DERM)Cambridge Investment Research Advisors Inc. purchased a new position in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 294,950 shares of the company's stock, vSeptember 4, 2024 | marketbeat.com4 lessons in the journey from PA to patientSeptember 1, 2024 | yahoo.comNew dermatologist joins Schlessinger MD in father-son collaborationAugust 25, 2024 | omaha.comRodman & Renshaw Initiates Coverage of Journey Medical (DERM) with Buy RecommendationAugust 23, 2024 | msn.comJourney Medical (NASDAQ:DERM) Receives New Coverage from Analysts at Rodman & RenshawRodman & Renshaw assumed coverage on Journey Medical in a research note on Thursday. They issued a "buy" rating and a $9.00 price objective on the stock.August 22, 2024 | marketbeat.comJourney Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 18, 2024 | finance.yahoo.comGet Longer, Stronger, and Thicker Hair With These Caffeine ShampoosAugust 16, 2024 | yahoo.comThe 12 Best Caffeine Shampoos for Thinning, Breaking, and Aging HairAugust 16, 2024 | msn.comJourney Medical Co. Expected to Post FY2024 Earnings of ($0.96) Per Share (NASDAQ:DERM)Journey Medical Co. (NASDAQ:DERM - Free Report) - Equities researchers at Roth Capital cut their FY2024 earnings estimates for Journey Medical in a report issued on Tuesday, August 13th. Roth Capital analyst J. Wittes now forecasts that the company will earn ($0.96) per share for the year, down fAugust 15, 2024 | marketbeat.com Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. DERM Media Mentions By Week DERM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DERM News Sentiment▼0.700.46▲Average Medical News Sentiment DERM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DERM Articles This Week▼73▲DERM Articles Average Week Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aquestive Therapeutics News Today Korro Bio News Today Taysha Gene Therapies News Today Foghorn Therapeutics News Today Tango Therapeutics News Today Verve Therapeutics News Today Larimar Therapeutics News Today Canopy Growth News Today 4D Molecular Therapeutics News Today Akebia Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DERM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
